CoQ10 may help lower the incidence of pre-eclampsia (high blood pressure) in pregnant women.

Women receiving 200 mg of CoQ10 a day had a 10 per cent lower risk of developing pre-eclampsia than women on placebo, according to results of the randomised, double-blind, placebo-controlled trial. Commenting on the potential mechanism, the researchers noted that the benefits of CoQ10 were most probably linked to its activity as an essential component of mitochondrial complexes I and III, in addition to its well-known antioxidant properties. In addition, numerous studies have demonstrated that using the cholesterol lowering class of drugs known as statins significantly decreases plasma levels of CoQ10, a nutrient essential to cellular energy production, and a powerful antioxidant. Supplementing with Co-Q10 is vital in individuals on a statin regimen.

IPM’s Co-Q10 supplies 100 mg. of CoQ10 per capsule using a highly absorbed oil based form.

Source: Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia.

Knock out prostate issues with this version of K.

Improved vitamin K2 status may reduce the risk of prostate cancer suggest results from German scientists, who last year, reported that increased intakes of vitamin K2, but not K1, were associated with a 35 per cent reduction in prostate cancer risk. The potential benefits of K2 were more pronounced for advanced prostate cancer. Lead author Katharina Nimptsch stated, “In this nested case-control study including 250 prostate cancer cases and 494 matched controls, we aimed to confirm this cancer-protective effect using serum undercarboxylated osteocalcin (ucOC), a biomarker of vitamin K status inversely associated with vitamin K intake.”

IPM’s Vitamin K2 drops are an ideal source of vitamin K.

Source: A Nested Case-Control Study in the Heidelberg Cohort of the European Prospective Investigation into Cancer and Nutrition.

For more information or to make an appointment, please call us at (949) 600-5100